SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-037429
Filing Date
2017-06-02
Accepted
2017-06-02 18:12:58
Documents
1
Period of Report
2017-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3955
  Complete submission text file 0001209191-17-037429.txt   5432
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MORRIS COMMUNICATIONS CORP 725 BROAD ST. AUGUSTA GA 30903
Business Address
RICCIARDI NATALE S (Reporting) CIK: 0001107158 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 17889368